Titan Biotech (BOM:524717) Institutional Ownership: 8.27% (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524717 Titan Biotech Ltd BOM:524717
52 GF Score
Price ₹437.15
GF Value ₹162.93
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Titan Biotech Institutional Ownership?

Titan Biotech BOM:524717 +0.67% 52 Institutional Ownership is 8.27% as of Sep. 14, 2026. GuruFocus rates BOM:524717 with a GF Score™ of 52/100 and a GF Value™ of ₹162.93 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Titan Biotech's institutional ownership is 8.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Titan Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Titan Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Titan Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Titan Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Titan Biotech Institutional Ownership Chart

Titan Biotech Historical Data

The historical data trend for Titan Biotech can be seen below:

2012-07-31 2012-08-31 2012-09-30 2012-10-31 2012-11-30 2012-12-31 2013-01-31 2013-02-28 2013-03-31 2013-04-30
Institutional Ownership 10.51 10.51 10.51 10.51 10.51 8.27 8.27 8.27 8.27 8.27
BOM:524717
52GF Score
Titan Biotech Ltd BOM:524717
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Titan Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 8.27% mean?
Titan Biotech (BOM:524717) has a Institutional Ownership of 8.27% as of Sep. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Titan Biotech and its competitors.
Is Titan Biotech's Institutional Ownership too high?
Titan Biotech's current Institutional Ownership is 8.27%. Overall, Titan Biotech has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Titan Biotech's Institutional Ownership compare to VRTX and REGN?
Titan Biotech's Institutional Ownership of 8.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Titan Biotech and its competitors. Titan Biotech's current Institutional Ownership is 8.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Titan Biotech stock overvalued right now?
Based on GuruFocus' analysis, Titan Biotech (BOM:524717) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹162.93, compared to a current price of ₹437.15 — trading 168.3% above its estimated fair value. The current Institutional Ownership is 8.27%. Titan Biotech's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Titan Biotech (BOM:524717), the current Institutional Ownership is 8.27% as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Titan Biotech (BOM:524717) Overvalued in 2026?

Based on GuruFocus' analysis, Titan Biotech stock appears to be overvalued. The current stock price of ₹437.15 is trading 168.3% above its estimated GF Value™ of ₹162.93. GuruFocus considers Titan Biotech to be Significantly Overvalued.

Key valuation signals for BOM:524717:

  • Institutional Ownership: 8.27%
  • GF Value™: ₹162.93 vs. price of ₹437.15 (168.3% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the BOM:524717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Titan Biotech Business Description

Address Netaji Subhash Place, 903-909, 9th Floor, Bigjos Tower, New Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters, and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The company's business activity falls within a single primary business segment, which is the business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
52GF Score

Get the complete analysis for BOM:524717

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹437.15
Price
₹162.93
GF Value